Browsing Centre for Haemato-Oncology by Author "Davies, JK"
Now showing items 1-7 of 7
-
Clinical outcome of coronavirus disease 2019 in haemato-oncology patients
Aries, JA; Davies, JK; Auer, RL; Hallam, SL; Montoto, S; Smith, M; Sevillano, B; Foggo, V; Wrench, B; Zegocki, K (2020) -
Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.
Davies, JK; Hassan, S; Sarker, S-J; Besley, C; Oakervee, H; Smith, M; Taussig, D; Gribben, JG; Cavenagh, JD (2018-02)Allogeneic haematopoietic stem-cell transplantation remains the only curative treatment for relapsed/refractory acute myeloid leukaemia (AML) and high-risk myelodysplasia but has previously been limited to patients who ... -
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
Araf, S; Wang, J; Korfi, K; Pangault, C; Kotsiou, E; Rio-Machin, A; Rahim, T; Heward, J; Clear, A; Iqbal, S (2018-05) -
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Davies, JK; Barbon, CM; Voskertchian, AR; Nadler, LM; Guinan, EC (2011-03) -
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation
Davies, JK; Brennan, LL; Wingard, JR; Cogle, CR; Kapoor, N; Shah, AJ; Dey, BR; Spitzer, TR; de Lima, M; Cooper, LJ (2018-09-01) -
Retinoic acid-responsive CD8 effector T-cells are selectively increased in IL-23-rich tissue in gastrointestinal GvHD.
Ball, JA; Clear, AJ; Aries, J; Charrot, S; Besley, C; Mee, M; Stagg, A; Lindsay, JO; Cavenagh, J; Calaminici, M (2020-09-09)Gastrointestinal (GI) graft-versus-host disease (GvHD) is a major barrier in allogeneic hematopoietic stem-cell transplantation (AHST). The metabolite retinoic acid (RA) potentiates GI-GvHD in mice via alloreactive T-cells ... -
TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses
Kotsiou, E; Okosun, J; Besley, C; Iqbal, S; Matthews, J; Fitzgibbon, J; Gribben, JG; Davies, JK (2016-07-07)